KUALA LUMPUR: Main Market-bound DXN Holdings Bhd has inked an underwriting agreement with Maybank Investment Bank Bhd, CIMB Investment Bank Bhd and RHB Investment Bank Bhd in conjunction with its initial public offering.
In a statement, health food supplements group DXN said the banks have agreed to underwrite the retail offering of 160 million shares in DXN, representing about 3.2% of the enlarged issued ordinary shares in DXN.
Of the shares, 60 million are reserved for the directors and eligible employees of DXN Group while 100 million are reserved for application by the Malaysian public via balloting.
Maybank Investment Bank is the principal adviser of the IPO, With CIMB Investment Bank, it is also joint global coordinator, joint bookrunner, joint managing underwriter and joint underwriter of the IPO..
RHB Investment Bank will serve as joint bookrunner and joint underwriter whereas CLSA Ltd and CLSA Securities Malaysia Sdn Bhd are joint global coordinators and joint bookrunners.
DXN operates a vertically integrated supply chain with in-house research, cultivation and manufacturing functions across Malaysia, China, India, Indonesia and Mexico, and have over 300 stock keeping units of health-oriented and wellness consumer products that are manufactured in-house and distributed through its direct selling network or sales branches.
"Since we began operations, we have expanded our presence from being solely in the Malaysian market into international markets.
"We have a vast distribution footprint spanning across various global regions of Europe, Latin America, North America, Central Asia, South Asia, Southeast Asia, Middle East, Africa and Oceania and we are eyeing our next stage of growth as we aim to expand into new markets,” said DXN non-independent executive chairman and founder Datuk Lim Siow Jin.